RNAi-based β-catenin inhibition in combination with MEK inhibition promotes synergistic anti-tumor efficacy and overcomes resistance with MEK inhibition promotes synergistic anti-tumor efficacy and overcomes resistance

被引：0
|
作者：
Ganesh, Shanthi
Shui, Serena
Chopda, Girish
Koser, Martin
Craig, Kevin
Dutta, Chaitali
Lai, Cheng
Dudek, Hank
Wang, Weimin
Brown, Bob D.
Abrams, Marc
机构：
来源：
CANCER RESEARCH | 2017年 / 77卷
关键词：
D O I：
10.1158/1538-7445.AM2017-1229
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1229
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Correction to: Inhibition of autophagy enhances synergistic effects of Salidroside and anti-tumor agents against colorectal cancer
    Hai Li
    Chen Chen
    BMC Complementary and Alternative Medicine, 18
  • [42] Synergistic anti-tumor activity and inhibition of angiogenesis by cotargeting of oncogenic and death receptor pathways in human melanoma
    G Grazia
    C Vegetti
    F Benigni
    I Penna
    V Perotti
    E Tassi
    I Bersani
    G Nicolini
    S Canevari
    C Carlo-Stella
    A M Gianni
    R Mortarini
    A Anichini
    Cell Death & Disease, 2014, 5 : e1434 - e1434
  • [43] Dual inhibition of the Akt pathway by Rapamycin and Perifosine induces synergistic anti-tumor activity in multiple myeloma
    Cirstea, Diana
    Hideshima, Teru
    Ikeda, Hiroshi
    Pozzi, Samantha
    Vallet, Sonia
    Vaghela, Nileshwari
    Okawa, Yutaka
    Santo, Loredana
    Shweta, Chhetri
    Chhetri, Gaurav
    Patel, Chirayu
    Yan, Hua
    Kiziltepe, Tanyel
    Breitkreutz, Iris
    Anderson, Kenneth
    Raje, Noopur
    CANCER RESEARCH, 2008, 68 (09)
  • [44] Synergistic anti-tumor activity and inhibition of angiogenesis by cotargeting of oncogenic and death receptor pathways in human melanoma
    Grazia, G.
    Vegetti, C.
    Benigni, F.
    Penna, I.
    Perotti, V.
    Tassi, E.
    Bersani, I.
    Nicolini, G.
    Canevari, S.
    Carlo-Stella, C.
    Gianni, A. M.
    Mortarini, R.
    Anichini, A.
    CELL DEATH & DISEASE, 2014, 5 : e1434 - e1434
  • [45] esRAGE-expressing oHSV enhances anti-tumor efficacy by inhibition of endothelial cell activation
    Swanner, Jessica
    Shim, Ji Seon
    Rivera-Caraballo, Kimberly A.
    Vazquez-Arreguin, Karina
    Hong, Bangxing
    Bueso-Perez, Alberto J.
    Lee, Tae Jin
    Banasavadi-Siddegowda, Yeshavanth Kumar
    Kaur, Balveen
    Yoo, Ji Young
    MOLECULAR THERAPY ONCOLYTICS, 2023, 28 : 171 - 181
  • [46] Leveraging T cell anti-tumor immunity to enhance the efficacy of Ras inhibition in pancreatic cancer
    Dalton, Tanner
    Wasko, Urszula
    Curiel-Garcia, Alvaro
    Sastra, Stephen
    Palermo, Carmine
    Hasselluhn, Marie
    Olive, Kenneth
    CANCER IMMUNOLOGY RESEARCH, 2024, 12 (10)
  • [47] Inhibiting ataxiatelangiectasia mutated and RAD3related (ATR) by BAY 1895344 overcomes chemoresistance to oxaliplatin and promotes synergistic anti-tumor effect in pancreatic cancer
    Shon, Hye Won
    Chun, Jung Won
    Gong, Jeong Eun
    Lee, Mi Rim
    Lee, Yu-Sun
    Kang, Sumin
    Kim, Sunshin
    Woo, Sang Myung
    Cho, In Rae
    Paik, Woo Hyun
    Lee, Woo Jin
    Ryu, Ji Kon
    Kim, Yong-Tae
    Lee, Sang Hyub
    Kim, Yun-Hee
    CANCER RESEARCH, 2023, 83 (07)
  • [48] Pulsatile MEK Inhibition Improves Anti-tumor Immunity and T Cell Function in Murine Kras Mutant Lung Cancer
    Choi, Hyejin
    Deng, Jiehui
    Li, Shuai
    Silk, Tarik
    Dong, Lauren
    Brea, Elliott J.
    Houghton, Sean
    Redmond, David
    Zhong, Hong
    Boiarsky, Jonathan
    Akbay, Esra A.
    Smith, Paul D.
    Merghoub, Taha
    Wong, Kwok-Kin
    Wolchok, Jedd D.
    CELL REPORTS, 2019, 27 (03): : 806 - +
  • [49] Class IIa HDAC inhibition promotes an anti-tumor macrophage phenotype that induces breast tumor regression and inhibits metastasis
    Guerriero, Jennifer L.
    Sotayo, Alaba
    Ponichtera, Holly
    Pourzia, Alexandra
    Schad, Sara
    Carrasco, Ruben
    Suzan, Lazo
    Bronson, Roderick
    Letai, Anthony
    CANCER IMMUNOLOGY RESEARCH, 2017, 5 (03)
  • [50] Hexokinase-II Inhibition Synergistically Augments the Anti-tumor Efficacy of Sorafenib in Hepatocellular Carcinoma
    Yoo, Jeong-Ju
    Yu, Su Jong
    Na, Juri
    Kim, Kyungmin
    Cho, Young Youn
    Lee, Yun Bin
    Cho, Eun Ju
    Lee, Jeong-Hoon
    Kim, Yoon Jun
    Youn, Hyewon
    Yoon, Jung-Hwan
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2019, 20 (06)
12345